Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats

This publication has 39 references indexed in Scilit:

• Azelnidipine, a New Long-acting Calcium-channel Blocker, Inhibits Tumour Necrosis Factor-α-induced Monocyte Chemoattractant Protein-1 Expression in Endothelial Cells
  Journal of International Medical Research, 2006
• Stroke Research Priorities for the Next Decade – A Representative View of the European Scientific Community
  Cerebrovascular Diseases, 2006
• Efficacy of Azelnidipine on Home Blood Pressure and Pulse Rate in Patients with Essential Hypertension: Comparison with Amlodipine
  Hypertension Research, 2006
• Amlodipine-Induced Reduction of Oxidative Stress in the Brain Is Associated with Sympatho-Inhibitory Effects in Stroke-Prone Spontaneously Hypertensive Rats
  Hypertension Research, 2006
• Effect of Azelnidipine on Angiotensin II-Mediated Growth-Promoting Signaling in Vascular Smooth Muscle Cells
  Molecular Pharmacology, 2005
• Pharmacological profiles and clinical effects of azelnidipine, a long-acting calcium channel blocker.
  Folia Pharmacologica Japonica, 2003
• Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2002
• 1,4-Dihydropyridine Calcium Channel Blockers Inhibit Plasma and LDL Oxidation and Formation of Oxidation-Specific Epitopes in the Arterial Wall and Prolong Survival in Stroke-Prone Spontaneously Hypertensive Rats
  Stroke, 1999
• Optimal Depth and Duration of Mild Hypothermia in a Focal Model of Transient Cerebral Ischemia
  Stroke, 1998
• Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion.
  Stroke, 1989